GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Mood disorders are associated with significant psychosocial and occupational disability. It is estimated that major depressive disorder (MDD) will become the second leading cause of disability worldwide by 2020. Existing pharmacological and psychological treatments are limited for targeting cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Inkster, Becky, Zai, Gwyneth, Lewis, Gemma, Miskowiak, Kamilla W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181907/
https://www.ncbi.nlm.nih.gov/pubmed/30310078
http://dx.doi.org/10.1038/s41398-018-0270-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181907/
https://www.ncbi.nlm.nih.gov/pubmed/30310078
http://dx.doi.org/10.1038/s41398-018-0270-z

Ejemplares similares